Kirin Cashes Out of Amgen Drug Joint Venture for $780M Post author:Sam Post published:October 30, 2017 Post category:BioPharma Amgen and Kirin have decided to dissolve their joint venture, Kirin-Amgen. Source: BioSpace You Might Also Like Marinus Pharma Provides Business Update And 2016 Financial Results March 12, 2017 Anika Therapeutics To Issue Third-Quarter 2017 Financial Results And Business Highlights On Wednesday, October 25 October 11, 2017 Bay Area Biotech Forges Multi-Year Research Deal with Genentech December 18, 2017
Anika Therapeutics To Issue Third-Quarter 2017 Financial Results And Business Highlights On Wednesday, October 25 October 11, 2017
